Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy

Infection and Immunity

Volumn 76, Issue 6, 2008, Pages 2587-2593

  Honaker, Ryan W ^a   Stewart, Amanda ^a   Schittone, Stephanie ^a   Izzo, Angelo ^b   Klein, Michèl R ^c,d   Voskuil, Martin I ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; NARK2 PROTEIN; NARX PROTEIN; UNCLASSIFIED DRUG; ANION TRANSPORT PROTEIN; NITRATE TRANSPORTERS;

ANAEROBIC METABOLISM; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BCG VACCINATION; DIAGNOSTIC VALUE; GENETIC TRANSCRIPTION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NITRATE METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULON; STRAIN DIFFERENCE; T LYMPHOCYTE; TUBERCULOSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANION TRANSPORT PROTEINS; BACTERIAL PROTEINS; BASE SEQUENCE; BCG VACCINE; GENE EXPRESSION REGULATION, BACTERIAL; MYCOBACTERIUM BOVIS; PHENOTYPE; PROMOTER REGIONS (GENETICS); REGULON;

EID: 46249094753     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01235-07     Document Type: Article

References (42)

1. Abebe, F., C. Holm-Hansen, H. G. Wiker, and G. Bjune. 2007. Progress in serodiagnosis of Mycobacterium tuberculosis Infection. Scand. J. Immunol. 66:176-191.
2. American Thoracic Society. 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm. Rep. 49:1-51.
3. Behr, M. A. 2002. BCG: different strains, different vaccines? Lancet Infect. Dis. 2:86-92.
4. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284:1520-1523.
5. Brooks, P. C., L. F. Dawson, L. Rand, and E. O. Davis. 2006. The Mycobacterium-specific gene Rv2719c is DNA damage inducible independently of RecA. J. Bacteriol. 188:6034-6038.
6. Castillo-Rodal, A. I., M. Castanon-Arreola, R. Hernandez-Pando, J. J. Calva, E. Sada-Diaz, and Y. Lopez-Vidal. 2006. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect. Immun. 74:1718-1724.
7. Cehovin, A., J. M. Cliff, P. C. Hill, R. H. Brookes, and H. M. Dockrell. 2007. Extended culture enhances sensitivity of a gamma interferon assay for latent Mycobacterium tuberculosis infection. Clin. Vaccine Immunol. 14:796-798.
8. Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins, and J. D. Thompson. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31:3497-3500.
9. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
10. Comstock, G. W. 1988. Identification of an effective vaccine against tuberculosis. Am. Rev. Respir. Dis. 138:479-480.
11. Demissie, A., E. M. Leyten, M. Abebe, L. Wassie, A. Aseffa, G. Abate, H. Fletcher, P. Owiafe, P. C. Hill, R. Brookes, G. Rook, A. Zumla, S. M. Arend, M. Klein, T. H. Ottenhoff, P. Andersen, and T. M. Doherty. 2006. Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin. Vaccine Immunol. 13:179-186.
12. Dinnes, J., J. Deeks, H. Kunst, A. Gibson, E. Cummins, N. Waugh, F. Drobniewski, and A. Lalvani. 2007. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol. Assess. 11:1-196.
13. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
14. Florczyk, M. A., L. A. McCue, A. Purkayastha, E. Currenti, M. J. Wolin, and K. A. McDonough. 2003. A family of Acr-coregulated Mycobacterium tuberculosis genes shares a common DNA motif and requires Rv3133c (DosR or DevR) for expression. Infect. Immun. 71:5332-5343.
15. Fritz, C., S. Maass, A. Kreft, and F. C. Bange. 2002. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect. Immun. 70:286-291.
16. Hill, P. C., R. H. Brookes, A. Fox, D. Jackson-Sillah, D. J. Jeffries, M. D. Lugos, S. A. Donkor, I. M. Adetifa, B. C. de Jong, A. M. Aiken, R. A. Adegbola, and K. P. McAdam. 2007. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 4:e192.
17. Hutter, B., and T. Dick. 2000. Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG. FEMS Microbiol. Lett. 188:141-146.
18. Hutter, B., and T. Dick. 1999. Up-regulation of narX, encoding a putative "fused nitrate reductase" in anaerobic dormant Mycobacterium bovis BCG. FEMS Microbiol. Lett. 178:63-69.
19. Kalendar, R. 2006. FastPCR, PCR primer design, DNA and protein tools, repeats and own database searches program. University of Helsinki, Helsinki, Finland. http://www.biocenter.helsinki.fi/bi/programs/fastpcr.htm.
20. Kumar, A., J. C. Toledo, R. P. Patel, J. R. Lancaster, Jr., and A. J. Steyn. 2007. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc. Natl. Acad. Sci. USA 104:11568-11573.
21. Leyten, E. M., M. Y. Lin, K. L. Franken, A. H. Friggen, C. Prins, K. E. van Meijgaarden, M. I. Voskuil, K. Weldingh, P. Andersen, G. K. Schoolnik, S. M. Arend, T. H. Ottenhoff, and M. R. Klein. 2006. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8:2052-2060.
22. Liberek, A., M. Korzon, E. Bernatowska, M. Kurenko-Deptuch, and M. Rytlewska. 2006. Vaccination-related Mycobacterium bovis BCG infection. Emerg. Infect. Dis. 12:860-862.
23. Lim, A., M. Eleuterio, B. Hutter, B. Murugasu-Oei, and T. Dick. 1999. Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J. Bacteriol. 181:2252-2256.
24. Mitchell, J. E., D. Zheng, S. J. Busby, and S. D. Minchin. 2003. Identification and analysis of "extended -10" promoters in Escherichia coli. Nucleic Acids Res. 31:4689-4695.
25. Pai, M., S. Kalantri, and K. Dheda. 2006. New tools and emerging technologies for the diagnosis of tuberculosis. I. Latent tuberculosis. Expert Rev. Mol. Diagn. 6:413-422.
26. Parish, T., and N. G. Stoker. 2001. Mycobacterium tuberculosis protocols. Humana Press, Totowa, NJ.
27. Park, H. D., K. M. Guinn, M. I. Harrell, R. Liao, M. I. Voskuil, M. Tompa, G. K. Schoolnik, and D. R. Sherman. 2003. Rv3133c/DosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48:833-843.
28. Roupie, V., M. Romano, L. Zhang, H. Korf, M. Y. Lin, K. L. Franken, T. H. Ottenhoff, M. R. Klein, and K. Huygen. 2007. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect. Immun. 75:941-949.
29. Sherman, D. R., M. Voskuil, D. Schnappinger, R. Liao, M. I. Harrell, and G. K. Schoolnik. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. USA 98:7534-7539.
30. Sohaskey, C. D. 2005. Regulation of nitrate reductase activity in Mycobacterium tuberculosis by oxygen and nitric oxide. Microbiology 151:3803-3810.
31. Sohaskey, C. D., and L. G. Wayne. 2003. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis. J. Bacteriol. 185:7247-7256.
32. Stermann, M., A. Bohrssen, C. Diephaus, S. Maass, and F. C. Bange. 2003. Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis. J. Clin. Microbiol. 41:3252-3259.
33. Stermann, M., L. Sedlacek, S. Maass, and F. C. Bange. 2004. A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis. J. Bacteriol. 186:2856-2861.
34. Virtanen, S. 1960. A study of nitrate reduction by mycobacteria. The use of the nitrate reduction test in the identification of mycobacteria. Acta Tuberc. Scand. Suppl. 48:1-119.
35. Voskuil, M. I., and G. H. Chambliss. 1998. The -16 region of Bacillus subtilis and other gram-positive bacterial promoters. Nucleic Acids Res. 26:3584-3590.
36. Voskuil, M. I., D. Schnappinger, K. C. Visconti, M. I. Harrell, G. M. Dolganov, D. R. Sherman, and G. K. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
37. Wayne, L. G. 2001. In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis. Methods Mol. Med. 54:247-269.
38. Wayne, L. G., and J. R. Doubek. 1965. Classification and identification of mycobacteria. Ii. Tests employing nitrate and nitrite as substrate. Am. Rev. Respir. Dis. 91:738-745.
39. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
40. Wayne, L. G., and L. G. Hayes. 1998. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis. 79:127-132.
41. Weber, I., C. Fritz, S. Ruttkowski, A. Kreft, and F. C. Bange. 2000. Anaerobic nitrate reductase (NarGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol. Microbiol. 35:1017-1025.
42. World Health Organization. 2007. Tuberculosis fact sheet number 104, revised March 2007. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs104/en/.